The role of TMS in non-pharmacological therapy
In modern medical practice, transcranial magnetic stimulation is actively used as an adjunctive or primary non-pharmacological modality. Neurological pathologies often require a combined approach, where physical therapy methods are integrated with pharmacotherapy.
According to clinical observations, the method holds a place in management protocols for patients with various functional disorders of the central nervous system. Its inclusion in rehabilitation regimens allows for non-invasive targeting of pathological foci, improving overall patient recovery rates.
Application in spasticity and multiple sclerosis
TMS is of particular importance in the treatment of multiple sclerosis (MS) patients aged 18 years and older diagnosed with spastic hypertonia syndrome.
- Target group: adult patients with manifestations of muscle spasticity.
- Main therapeutic goals: correction of increased muscle tone, reduction of pain syndrome, as well as prevention and treatment of joint contractures.
- Evidence base: the method has high levels of reliability (Grade A, Level 2 Evidence) alongside physical therapy and specialized procedures.
Short-term (up to 1 week) and medium-term (up to 6 months) observations confirm the clinical efficacy of TMS in this patient group.
Efficacy compared to other methods
Analysis of the clinical efficacy of various physiotherapeutic approaches allows for a clear distinction between modalities with proven benefit and methods that have not been confirmed effective in studies.
- Effective approaches: In addition to TMS, positive results are shown by regular physical therapy (stretching and contraction exercises for antagonist muscles) and a combination of physical therapy with botulinum toxin therapy.
- Ineffective methods: In studies, transcutaneous electrical nerve stimulation (TENS), whole-body vibration, and alternative practices such as yoga and rock climbing did not demonstrate statistically significant efficacy in treating spasticity.
Thus, the choice of methodology must be based strictly on a robust evidence base.
TMS — Precise Magnetic Stimulation for relieving spasticity in multiple sclerosis.
Class and exam questions
What is the level of evidence for TMS in the treatment of spasticity in patients with multiple sclerosis?
The use of transcranial magnetic stimulation in the comprehensive treatment of spastic hypertonia has a high level of recommendation A (Level 2 Evidence).
Over what timeframes is the clinical efficacy of TMS evaluated?
The efficacy of the method is evaluated in the short term (up to 1 week) and medium term (up to 6 months).
What other methods are included in the group of effective non-pharmacological interventions for spasticity?
Effective methods include physical therapy (PT) with muscle stretching and contraction exercises, as well as a combination of PT with botulinum toxin type A injections.
What else to study on this topic
- Cognitive behavioral therapy for neuropathic pain and diabetes mellitus
- Use of resting splints and serial casting
- Antiemetic therapy and transcutaneous electrical nerve stimulation
- Features of physical therapy in brain diseases
- Methods of botulinum toxin type A injections in spastic syndrome
Master the entire topic in the "Neurology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Transcranial magnetic stimulation" and 907 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 32 video lessons for the subject
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.